1. An RP., Liu GG., et al., “Dietary habits and cognitive impairment risk among oldest-old Chinese," Journal of Gerontology: Social Sciences, 2017, forthcoming.

2. Liu GG., “Building A National Health System,” China Economic Quarterly, 2017, 21(1): 16-23.

3. Hu XF, Liu GG., and Fan M., “Long-Term Effects of Famine on Chronic Diseases: Evidence from China’s Great Leap Forward Famine,” Health Economics, 2016 Jun 16. doi: 10.1002/hec.3371.

4. Liu GG., et al., “How Much Does Social Status Matter to Longevity? – Evidence from China’s Academician Election,” Health Economics, 2017, 26(3):292-304.

5. Liu GG., Vortherms SA., and Hong XZ, “China’s health reform update,” Annual Review of Public Health, 2017, 38: 431-448.

6. Liu MY., Qin XZ., Pan J., "Does Medical Equipment Expansion Lead to More Diagnostic Services? Evidence from China's Sichuan Province." Emerging Markets Finance and Trade, 2017, forthcoming.

7. Luo N., Liu GG. Li M., Guan H, Jin X, and Rand-Hendriksen K., “Estimating an EQ-5D-5L value set for China,” Value in Health, 2017 Apr;20(4):662-669.

8. Qin XZ., Zhuang C., Yang RD., "Does the One-Child Policy Improve Children's Human Capital in Urban China? A Regression Discontinuity Design." Journal of Comparative Economics, 2017, forthcoming.

9. Qin XZ., Wang SY., Chee-Ruey Hsieh., "The Prevalence of Depression and Depressive Symptoms among Adults in China: Estimation Based on a National Household Survey." China Economic Review, 2017, forthcoming.

10. Zhang C, Lei X, Strauss J, et al. "Health Insurance and Health Care among the Mid-Aged and Older Chinese: Evidence from the National Baseline Survey of CHARLS,”. Health Economics, 2017, forthcoming.

11. An RP., and Liu GG., “Cognitive Impairment and Mortality among the Oldest-old Chinese," International Journal of Geriatric Psychiatry, 2016, 31(12):1345-1353.

12. Fan M., Lei Z., and Liu GG., “Discounting of Medical Savings Accounts,” American J of Health Economics, 2016,2(2):161-183.

13. Huang W, Lei X, Zhao Y. "One-Child Policy and the Rise of Man-Made Twins,” The Review of Economics and Statistics, 2016, 143(3):97-100.

14. Jin XJ., Liu GG., et al., “Is bad living better than good death? Impact of demographic and cultural factors on health state preference,” Quality of Life Research, 2016, 25(4):979-986.

15. Lei X, Shen Y, Smith J P, et al. "Sibling gender composition’s effect on education: evidence from China,” Journal of Population Economics, 2016:1-22.

16. Liu GG., Xue XD., Yu C., Wang YF., “How does social capital matter to the health status of older adults? Evidence from the China Health and Retirement Longitudinal Survey,” Economics and Human Biology, 2016, 22:177-189.

17. 何泱泱、刘国恩、徐程, “中国职业隔离与性别工资差异的变化趋势研究,” 《经济科学》，2016(4):78-89.

18. 刘国恩、官海静,“分级诊疗与全科诊所：中国医疗供给侧改革的关键,”《中国全科医学》，2016：2619-2624.

19. Pan J., Qin XZ., Chee-Ruey Hsieh. “Is the Pro-Competition Policy an Effective Solution for China's Public Hospital Reform?” Health Economics, Policy and Law, 2016,11(4): 337-357. 

20. Pan J, Zhao H, Wang X, et al. “Assessing spatial access to public and private hospitals in Sichuan, China: The influence of the private sector on the healthcare geography in China.” Social Science & Medicine, 2016, 170:35-45.

21. Pan J., Lei XY., and Liu GG., “Health Insurance and Health Status: Exploring the Causal Effect from A Policy Intervention,” Health Economics, 2016, 25(11):1389-1402.

22. Qin XZ., Jay Pan. “The Medical Cost Attributable to Obesity and Overweight in China: Estimation Based on Longitudinal Surveys.” Health Economics, 2016,25(10): 1291–1311. 

23. Qin XZ., Wang TY., Zhuang C., “Intergenerational Transfer of Human Capital and Its Impact on Income Mobility: Evidence from China.” China Economic Review, 2016,38: 306–321. 

24. Shi J., "Income Manipulation to Subsidized Health Insurance Programs: Evidence from Massachusetts," American Journal of Health Economics, 2016, 2(1): 96-124

25. Stevens W., Liu GG., et al., “Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China,” BMC Health Services Research, 2016, 16(1): 175.

26. Zhou Q., Liu GG., Krumholz S., “Is Chinese National Health Insurance Effective in the Face of Severe Illness? A Perspective from Health Service Utilization and Economic Burden,” Soc Evidence from China ial Indicators Research, 2016:1-23.

27. Zhou Q., Liu GG. et al., “The Impact of Health Insurance Cost-Sharing Method on Healthcare Utilization in China,” China Journal of Social Work, 2016, 9(1):38-61..

28. Li Q, Liu GG., and Zang WB, “The Health of Left-behind Children in Rural China,” China Economic Review, 2015, 36:367-376.

29. Lei X, Strauss J, Tian M, et al. “Living arrangements of the elderly in China: evidence from the CHARLS national baseline,” China Economic Journal,” 2015, 8(3):191.

30. Lei X, Shen Y, Smith J P, et al. “Do social networks improve Chinese adults’ subjective well-being?,” Journal of the Economics of Ageing, 2015, 6:57-67.

31. Lei X, Shen Y. “Inequality in educational attainment and expectation: evidence from the China Family Panel Studies,” China Economic Journal, 2015, 8(3):1-12.

32. Pan J., Qin XZ., Qian Li., Messina J., Delamater P., “Does Hospital Competition Improve Health Care Delivery in China?” China Economic Review, 2015,33: 179-199. 

33. Rose S., Shi J., McGuire T., Normand S., "Matching and Imputation Methods for Risk Adjustment in Health Insurance Exchanges," Statistics in Biosciences, 2015:1-18. 

34. Wang P., Li MH., Liu GG., Thumboo J., and Luo N., “Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese,” European J of Health Economics, 2015 (16): 857–863.

35. Xu J., Liu GG. et al., “A comparison of outpatient healthcare expenditures between public and private medical institutions in urban China: an instrumental variable approach,” Health Economics, 2015(24): 270-279.

36. 官海静，刘国恩，“中国城乡居民生命质量的比较研究，”《中国卫生经济》，2015 (2):5-12.

37. Barredo L., Agyepong I., Liu GG., and Reddy S., “Ensure healthy lives and promote well-being for all at all ages,” UN CHRONICLE, 2014: No. 4.

38. Wang P, Li MH, Liu GG., Thumboo J., and Luo N., “Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese,” European J of Health Economics, 2014:1-7.

39. Eriksson T., Pan J., Qin XZ., “The Intergenerational Inequality of Health in China.” China Economic Review, Vol. 31: 392-409, December 2014. 

40. Liu GG., Wu HY., Li MH., Gao C., and Luo N., “Chinese time trade-off values for EQ-5D health states,” Value in Health, 2014 (17): 597–604.

41. Lei X, Sun X, Strauss J, et al. “Depressive symptoms and SES among the mid-aged and elderly in China: Evidence from the China Health and Retirement Longitudinal Study national baseline,” Social Science & Medicine, 2014, 120(1982):224.

42. McGuire T., Newhouse J., Normand S., Shi J., and Zuvekas S.,"Assessing Incentives for Service-Level Selection in Private Health Insurance Exchanges," Journal of Health Economics, 2014, 35, 47-63

43. 潘杰，刘国恩，尹庆双，“医疗体制管办分开与服务供给，”《经济学报》，2014 （1）：33-50.

44. Wu J., Xu J., Liu GG., “Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals,” PharmacoEconomics, 2014 (32):293-303.

45. Liu GG., Yiqun Chen, Qin XZ., “Transforming Rural Health Care through Information Technology: An Interventional Study in China.” Health Policy and Planning, 2014,29(8): 975-985. 

46. Liu GG. and Krumholz S., “Economics of health transition in China,” The Oxford Companion to the Economics of China, edited by Ravi Kanbur et al., Oxford University Press, 2014.

47. Qin XQ, Pan J, and Liu GG., “Does participating in health insurance benefit the migrant workers in China? an empirical investigation,” China Economic Review, 2014 (30): 263-278.

48. Qin XZ., Chee-Ruey Hsieh., “Economic Growth and the Geographic Maldistribution of Health Care Resources: Evidence from China, 1949-2010.” China Economic Review, 2014,31: 228-246. 

49. 兰烯，刘国恩，李林，“医疗机构产权性质对医疗服务质量的影响，”《中国经济问题》，2014（2）：67-78.

50. 雷晓燕, 许文健, 赵耀辉. “高攀的婚姻更令人满意吗?婚姻匹配模式及其长远影响，”. 《经济学:季刊》, 2014(4):31-50.

51. 李琴, 雷晓燕, 赵耀辉. “健康对中国中老年人劳动供给的影响，” 《经济学:季刊》, 2014, 13(3):917-938.

52. Gao C., Xu F., Liu GG., “Payment reform and changes in health care in China,” Social Science & Medicine, 2014 (111): 10-16.

53. Chen G, Liu GG., and Xu F., "The impact of the urban resident basic medical insurance in China on health services utilization," PharmacoEconomics, 2014 (32): 277-292.

54. 赵绍阳，臧文斌，傅十和，刘国恩，“强制医保制度下无保险人群的健康状况研究，”《经济研究》，2013 (7): 118-131.

55. Pan J., Liu GG., and Gao C., “How does separating government regulatory and operational control of public hospitals matter to healthcare supply?” China Economic Review, 2013 (27):1–14.

56. McGuire T., Glazer J., Newhouse J., Normand J., Shi J., Sinaiko A., and Zuvekas S., "Integrating Risk Adjustment and Enrollee Premiums in Health Plan Payment," Journal of Health Economics, 2013, 32 (6), 1263–1277 

57. 刘国恩,:《转变经济发展方式靠什么:论两只看不见的手》, 2013《比较》第3期.

58. Qin XZ., Liu GG., “Does the U.S. Health Care Safety Net Discourage Private Insurance Coverage?” European Journal of Health Economics, 2013,14 (3): 457-469. 

59. Luo N., Li M., and Liu GG., “Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach,” Quality of Life Research, 2013, 22(4):885-890.

60. 潘杰, 雷晓燕,刘国恩,:《医疗保险促进健康吗？》,《经济研究》, 2013(4):130-142.

61. Liu YJ, Xue YJ, Liu GG., “Development of foreign invested hospitals in China: obstacles and coping strategies,” Journal of Hospital Administration, 2013, 2 (3).

62. Qin XZ. and Liu GG., “Does the U.S. healthcare safety net discourage private insurance coverage?” European J of Health Economics, 2013, 2(3).

63. Fu AZ., Zhao ZY, Liu GG., “Hospital costs of adverse events in patients with metastatic colorectal cancer,” Journal of Cancer Therapy, 2013, 04(1):153-158.

64. 高月霞,徐程,:《另辟蹊径---淮安总额控制下按病种分值结算方式改革》,《中国社会保障》2013第4期.

65. 高月霞,倪倬健,李小杉,:《1989-2009年海门市糖尿病死亡分析及预测》,《中国卫生统计》2013, 30(1):74-76.

66. 高月霞,李奕辰,宗蕾,:《南通市高血压健康知识及影响因素分析》,《中国公共卫生》2013, 29(4):496-499.

67. 高月霞,李奕辰,刘国恩,:《基本药物制度对南通市社区卫生服务机构门诊合理用药的影响分析》,《中华医院管理杂志》2013, 29(7):488-491.

68. 高月霞,徐程,刘国恩,:《社会支持对老年人健康相关生命影响的研究—基于南通的实证》,《人口与发展》, 2013, 19(4):73-81.

69. Wu EQ, Xie JP, Liu GG., “Trend in economic burden of diabetes in urban china from 2009 to 2011,” Value in Health, 2013, 16(3): A161.

70. 官海静,刘国恩,熊先军,:《城镇居民基本医疗保险对住院服务利用公平性的影响》,《中国卫生经济》2013(1):42-44.

71. 官海静,刘国恩,熊先军,:《中国城镇居民的健康公平和健康绩效》,《中国卫生经济》2013(9):33-37.

72. 刘国恩,官海静,高晨,:《中国社会办医的现况分析》,《中国卫生政策研究》, 2013, 6(9):41-46.

73. 程迪尔,官海静,刘国恩,:《生活水平指标选择对健康公平测算结果的影响》,《中国卫生经济》, 2013, 32(3):79-81.

74. 孙艳坤,刘国恩,李幼平,:《化疗与利妥昔单抗联用治疗非霍奇金淋巴瘤的药物经济学系统评价》,《中国循证医学》, 2013, 13(6):700-708.

75. 周钦, 臧文斌,刘国恩,:《医疗保障水平与中国家庭的医疗经济风险》,《保险研究》, 2013(7):95-107.

76. 朱琳, 刘国恩, 李冬美,等.《儿童七价肺炎球菌结合疫苗的成本效果分析》. 《中国卫生经济》, 2013(4):71-75.

77. 高月霞,孙华,刘国恩,《尿毒症透析治疗的价格谈判机制研究》,《社会保障研究》, 2012(1):35-40.

78. 刘明,刘国恩,:《药物经济学在药品定价中应用的定位分析》,《中国药物经济学》, 2012(6):6-9.

79. Pan J,Qin XZ., and Liu GG. , “The Impact of body size on urban employment: evidence from China ,”China Economic Review, 2012, 27(4):249-263.

80. Liu G G, Md D B, Yuan Y, et al. “The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan,” Value in Health, 2012, 15(1 Suppl):S65–S71.

81. 臧文斌, 刘国恩,徐菲,等:《中国城镇基本医疗保险对家庭消费的影响》,《经济研究》, 2012(7):75-85.

82. 臧文斌, 赵绍阳, 刘国恩,《城镇基本医疗保险中逆向选择的检验》,《经济学(季刊)》, 2012, 12(4):47-70.

83. 徐程,尹庆双,刘国恩,《健康经济学研究新进展》,《经济学动态》, 2012(9):120-127.

84. 胡宏伟,刘国恩,《城镇居民医疗保险对国民健康的影响效应与机制》,《南方经济》, 2012, 30(10):186-199.

85. 薛新东,刘国恩,《社会资本决定健康状况吗？来自中国健康与养老追踪调查的证据》,《财贸经济》, 2012(8):113-121.

86. 肖静,高月霞,刘国恩,《6168例肝癌患者住院费用影响因素的通径分析》,《中国卫生经济》, 2012, 31(1):73-75.

87. 朱琳,刘美娟,《肺炎链球菌性疾病流行病学及小儿肺炎疫苗的综述》,《亚洲社会药学》,2012, 7(2): 85-90.

88. 秦雪征,刘国恩,《医疗保险对劳动力市场的影响研究评述》,《经济学动态》, 2011(12):114-119.

89. Pan J and Liu GG., “The determinants of Chinese provincial government health expenditures: evidence from 2002-2006 data,” Health Economics, 2012, 21(7):757.

90. 潘杰,秦雪征,刘国恩,《体型对城市劳动力就业的影响》,《南开经济研究》, 2011(2):68-85.

91. 刘国恩,蔡春光,李林,《中国老人医疗保障与医疗服务需求的实证研究》,《经济研究》, 2011(3):95-107.

92. 潘杰,《医疗护理困局下的“管办分开”》,《中国社会保障》, 2011(2):84-85.

93. 潘杰,《多点执业受阻“人事藩篱”》,《中国社会保障》, 2011(4):69-69.

94. 潘杰,徐菲,刘国恩,等《台湾地区全民健康保险制度建立对内地医改的启示》,《中国卫生经济》, 2011, 30(7):42-44.

95. 王鹏,刘国恩,《我国城镇居民病伤治疗措施选择的影响因素分析:来自我国9城市的微观证据》,《中国卫生经济》, 2011, 30(9):60-63.

96. 王弈冬,岳晓萌,吴久鸿,《药物相关问题的国际监测干预与经济性分析》,《中国药物应用与监测》, 2011, 08(3):176-180.

97. 刘国恩,王钊,鲍贻倩,《中国农村育龄妇女乙肝预防教育干预效果研究》,《中国卫生经济》, 2011, 30(5):13-15.

98. 朱琳,孙利华,刘国恩, 等《关于药品招标中质量分层的思考》,《中国药房》, 2010, v.21;No.310(40):3774-3777.

99. Qiu Y, Fu A, Liu GG., “Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Program,” Applied Health Economics and Health Policy, 2010, 8(3):167-77.

100. 李洪超,张银花,刘国恩,《糖尿病治疗指标终点综述与复合重点的权重构建》,《中国药物经济学》, 2010(2):42-53.

101. 李明晖,刘国恩,马爱霞,《中国城乡居民健康相关生存质量研究》,《中国药物经济学》, 2010(3):22-34.

102. 李强,臧文斌,《父母外出对留守儿童健康的影响》,《经济学(季刊)》, 2010, 10(1).

103. 刘国恩,《医改评估要看结果》,《中国医院院长》, 2010(19):14-14.

104. 潘杰,刘国恩,《卫生体制”管办”怎么分?》,《中国社会保障》, 2010(9):78-80.

105. 王鹏,刘国恩,《健康人力资本与性别工资差异》,《南方经济》, 2010, 28(9):73-84.

106. 赵绍阳,《疾病冲击与城镇家庭消费保险能力研究——基于对城镇家庭追踪调查数据的实证分析》,《中国人口科学》, 2010(5):66-74.

107. 朱琳,孙利华,刘国恩, 等.《关于药品招标中质量分层的思考》,《中国药房, 2010, v.21;No.310(40):3774-3777.